StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Swedish Orphan Biovitrum AB (publ)
Stockholm Stock Exchange:SOBI.ST
Sector
Location
Market Cap
USD 10.23 B
Share Price
USD 29.69
Avg Daily Volume
337,805
Change (1 day)
-0.40%
Change (1 year)
11.62%
Change (YTD)
3.60%
Swedish Orphan Biovitrum AB (publ) Operating Cash Flow for the year ending December 31, 2024: USD 664.92 M
Swedish Orphan Biovitrum AB (publ) Operating Cash Flow is USD 664.92 M for the year ending December 31, 2024, a 50.71% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Swedish Orphan Biovitrum AB (publ) Operating Cash Flow for the year ending December 31, 2023 was USD 441.19 M, a -0.97% change year over year.
-
Swedish Orphan Biovitrum AB (publ) Operating Cash Flow for the year ending December 31, 2022 was USD 445.51 M, a -26.03% change year over year.
-
Swedish Orphan Biovitrum AB (publ) Operating Cash Flow for the year ending December 31, 2021 was USD 602.25 M, a -4.70% change year over year.
-
Swedish Orphan Biovitrum AB (publ) Operating Cash Flow for the year ending December 31, 2020 was USD 631.94 M, a 63.44% change year over year.
Competitors
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Novo Nordisk A/S
USD 69.43
NOVO-B.CO
-1.17
-1.65%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
Novartis AG
USD 122.69
NOVN.SW
+0.12
0.10%
Abbott Laboratories
USD 133.22
ABT
-0.14
-0.10%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Vertex Pharmaceuticals Incorporated
USD 478.96
VRTX
+12.60
2.70%
Bristol-Myers Squibb Company
USD 47.66
BMY
+0.62
1.32%
GSK plc
USD 19.36
GSK.L
+0.16
0.81%
CSL Limited
USD 159.25
CSL.AX
-1.34
-0.84%
Chugai Pharmaceutical Co., Ltd.
USD 46.51
4519.T
-0.57
-1.20%
Regeneron Pharmaceuticals, Inc.
USD 552.58
REGN
+4.83
0.88%
MERCK Kommanditgesellschaft auf Aktien
USD 130.44
MRK.DE
-0.41
-0.31%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.96
600276.SS
+0.52
7.00%
Takeda Pharmaceutical Company Limited
USD 30.27
4502.T
+0.31
1.03%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Novo Nordisk A/S
USD 69.43
NOVO-B.CO
-1.17
-1.65%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
Novartis AG
USD 122.69
NOVN.SW
+0.12
0.10%
Abbott Laboratories
USD 133.22
ABT
-0.14
-0.10%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Vertex Pharmaceuticals Incorporated
USD 478.96
VRTX
+12.60
2.70%
Bristol-Myers Squibb Company
USD 47.66
BMY
+0.62
1.32%
GSK plc
USD 19.36
GSK.L
+0.16
0.81%
CSL Limited
USD 159.25
CSL.AX
-1.34
-0.84%
Chugai Pharmaceutical Co., Ltd.
USD 46.51
4519.T
-0.57
-1.20%
Regeneron Pharmaceuticals, Inc.
USD 552.58
REGN
+4.83
0.88%
MERCK Kommanditgesellschaft auf Aktien
USD 130.44
MRK.DE
-0.41
-0.31%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.96
600276.SS
+0.52
7.00%
Takeda Pharmaceutical Company Limited
USD 30.27
4502.T
+0.31
1.03%